Mirae Asset Global Investments Co. Ltd. decreased its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 46.7% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,994 shares of the health services provider's stock after selling 6,998 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Maximus were worth $545,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Hillsdale Investment Management Inc. boosted its position in Maximus by 0.4% during the 4th quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock worth $3,912,000 after acquiring an additional 230 shares during the period. UMB Bank n.a. increased its position in Maximus by 70.2% in the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after buying an additional 250 shares during the period. Bridge City Capital LLC grew its holdings in shares of Maximus by 0.9% during the 4th quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider's stock worth $2,128,000 after purchasing an additional 254 shares in the last quarter. Inspire Advisors LLC boosted its stake in Maximus by 3.1% in the 4th quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider's stock valued at $646,000 after buying an additional 258 shares in the last quarter. Finally, GAMMA Investing LLC boosted its stake in Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after buying an additional 294 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.
Insider Activity
In related news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director directly owned 14,205 shares in the company, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Check Out Our Latest Report on Maximus
Maximus Price Performance
Maximus stock traded down $0.38 on Friday, reaching $72.06. The company's stock had a trading volume of 224,629 shares, compared to its average volume of 573,642. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.84 and a current ratio of 1.84. The company has a market cap of $4.06 billion, a price-to-earnings ratio of 14.33 and a beta of 0.61. The business's fifty day moving average price is $71.18 and its 200 day moving average price is $70.96. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97.
Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The firm's quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.57 earnings per share. Equities analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th were issued a $0.30 dividend. The ex-dividend date was Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.67%. Maximus's dividend payout ratio (DPR) is currently 23.86%.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.